Aaron Nagiel, MD, PhD

Assistant Professor of Clinical Ophthalmology

Image of Aaron Nagiel, MD, PhD
Is this your profile? Click to edit

Overview

The development and maintenance of specific synaptic connections between retinal neurons is critical to its function. However, our understanding of neural circuit formation in the human retina remains limited. Within the last 10 years it has become possible to grow 3-dimensional, multi-layered retinal organoids derived from human stem cells. This advance permits the study of human retinal development and the establishment of synaptic connectivity. Our goal is to elucidate mechanisms underlying synapse formation and specificity in the first synapse of the human visual system. Access to patient-derived organoids allows us to understand this process in the disease state and following novel treatment paradigms such as gene therapy and cell-based therapy. We utilize a variety of techniques including live fluorescent imaging, electrophysiology, and gene editing in stem cell-derived human retinal organoids. The long-term goal of this work is to understand how synaptic connections are established and maintained in the human nervous system.

Visit our lab website: nagiellab.org

Awards

  • Harvard University: Detur Prize, 2001
  • John Harvard Scholarship, 2001
     – 2003
  • Finalist, Paul and Daisy Soros Fellowship for New Americans, 2006
  • The Rockefeller University: Sumi Koide Travel Fellowship, 2010
  • Jules Stein Eye Institute: Robert E. Christensen Research Award, 2013
  • ARVO National Eye Institute Travel Grant, 2014
  • Jules Stein Eye Institute: Excellence in Research Award, 2014
  • Jules Stein Eye Institute: Pepose-Saltzman Young Investigator ARVO Award, 2014
     – 2015
  • Heed Foundation Residents Retreat Participant, 2014
  • Heed Ophthalmic Foundation Fellowship, 2015
     – 2016
  • Jules Stein Eye Institute: Excellence in Research Award, 2016
  • Ronald G. Michels Fellowship Foundation Award, 2016
     – 2017
  • Allergan FIRST (Fostering Innovative Retina Stars of Tomorrow) Fellowship, 2016
     – 2019
  • Michels Fellowship Foundation: Ronald G. Michels Fellowship, 2016
     – 2017
  • Donald E. and Delia B. Baxter Foundation: Baxter Foundation Fellowship, 2019
     – 2020
  • Research to Prevent Blindness: RPB Career Development Award, 2021
     – 2023

Education and Training

  • Weill Cornell Medical College — MD
  • The Rockefeller University — PhD
  • Memorial Sloan-Kettering Cancer Center — Internship
  • UCLA Jules Stein Eye Institute — Residency — Ophthalmology
  • UCLA Jules Stein Eye Institute — Fellowship — Vitreoretinal

Research Keywords

  • Synaptogenesis
  • Retinal development
  • Human retinal organoids
  • Inherited retinal diseases
  • Medical and surgical management of retinal diseases

Media

Publications

  • Clinical features, retinal detachment (RD) rates, and RD prophylaxis in patients with genetically confirmed Knobloch Syndrome, a U.S.-based multi-center study. Ophthalmol Retina. 2026 Sep 08.. View in PubMed
  • Wnt Pathway Agonism as a Therapeutic Strategy for Retinal Vascular Diseases: A Narrative Review of Evidence to Date. Ophthalmol Ther. 2026 Oct; 15(10):3225-3243.. View in PubMed
  • Interim Results from a Multicenter Observational Safety Study of Patients Treated with Voretigene Neparvovec-Rzyl in the United States. Ophthalmology. 2026 Jul 22.. View in PubMed
  • COG5-congenital disorder of glycosylation diagnosed by whole genome sequencing in siblings with unexplained optic atrophy, macular atrophy, and developmental delay: case report. Front Neurol. 2026; 17:1840802.. View in PubMed
  • mGluR6 coordinates cone terminal targeting and synaptic layer assembly during human retinal development. bioRxiv. 2026 Apr 27.. View in PubMed
  • Self-Constructed Macular Buckle for Myopic Macular Hole-Associated Retinal Detachment. Am J Ophthalmol. 2026 Jun; 286:e1-e2.. View in PubMed
  • Expert Consensus on Characteristics, Etiology, and Management of Chorioretinal Atrophy in Patients Treated with Voretigene Neparvovec. Ophthalmol Sci. 2026 Apr; 6(4):101090.. View in PubMed
  • Pharmacologic Inhibition of YAP/TEAD and Development of New Chorioretinal Atrophy. JAMA Ophthalmol. 2026 01 01; 144(1):99-103.. View in PubMed
  • OCT-Derived Quantitative Measurement of Extent of Vascularization (“Zone”) in Retinopathy of Prematurity. Ophthalmol Sci. 2026 Jan; 6(1):100912.. View in PubMed
  • Baylisascariasis (Raccoon Roundworm Infection) in Two Unrelated Children – Los Angeles County, California, 2024. MMWR Morb Mortal Wkly Rep. 2025 Jul 31; 74(28):444-449.. View in PubMed